IP Library Granted Patent US 10,111,916
Granted Patent B2
US 10,111,916 · App. 15/272,689 · Granted Oct 30, 2018

Compositions comprising

Inventors: Sean Farmer (North Miami Beach, FL); Andrew R. Lefkowitz (Mayfield Heights, OH)
Assignee: Ganeden Biotech, Inc.
A61K35/742A23L33/10A23L33/125A23L33/135A23L33/175A61K9/0053A61K35/744A61K38/465A61K38/47A61K45/06A23V2002/00A61K2035/11
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,111,916
App. No.
15/272,689
Granted
Oct 30, 2018
Kind
B2
Abstract

The invention relates generally to digestive disorders, and in particular to methods for treating irritable bowel syndrome by increasing carbohydrate absorption by administering a composition containing a Bacillus coagulans bacterium.

Claims (15)

1. A composition which is in powdered or granular form, comprising Bacillus coagulans spores and a component obtained from the milk of a cow, sheep or goat, wherein the component is whey, and wherein said Bacillus coagulans is GBI-30, ATCC Designation Number PTA-6086.

2. The composition of claim 1 , further comprising a vitamin or a mineral.

3. The composition of claim 1 , further comprising an isolated amino acid.

4. The composition of claim 3 , wherein said isolated amino acid comprises histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, or valine.

5. The composition of claim 1 , further comprising lactose or fructose.

6. The composition of claim 1 , further comprising inulin.

7. The composition of claim 1 , further comprising sorbitol, maltose, sucrose, or mannan.

8. The composition of claim 1 , further comprising a sugar substitute.

9. The composition of claim 1 , further comprising a non-dairy creamer.

10. The composition of claim 1 , further comprising a protease or an amylase.

11. The composition of claim 1 , further comprising a lipase or a lactase.

12. The composition of claim 1 , further comprising a bifidogenic oligosaccharide.

13. The composition of claim 1 , further comprising silicone, starch, talc, calcium phosphate, calcium sulfate, calcium stearate, magnesium stearate, stearic acid, sorbitol, mannitol, gelatin, a natural gum, or a synthetic gum.

14. The composition of claim 1 , further comprising carboxymethylcellulose, methylcellulose, an alginate, a dextran, acacia gum, karaya gum, locust bean gum, or tragacanth.

15. The composition of claim 1 , which is a dietary supplement.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2017
From: FARMER, SEAN; LEFKOWITZ, ANDREW R.
To: GANEDEN BIOTECH, INC.
Reel/Frame 041366/0582 →
Continuity (6)
Continuation 13729505 · Dec 28, 2012
Continuation 12365808 · Feb 4, 2009
Division 10581781
Continuation In Part 10915030 · Aug 9, 2004
Provisional Application 60528074 · Dec 5, 2003
Related Publication 20170035813A1 · Feb 9, 2017